Telaprevir

Three Upcoming Make-or-Break Biotech Approvals
Seeking Alpha
Sun, 12/19/10 - 11:22 am
Vertex Pharmaceuticals
Telaprevir
Merck
hepatitis C
cystic fibrosis
Human Genome Sciences
Benlysta
lupus
MannKind
Afrezza
inhaled insulin
Director Of Equity Research At RBC Capital Markets Covers Phase III Data For Multiple New Drugs; Find Out The Stocks That Investors Should Look At
Yahoo/Wall Street Transcript
Sat, 12/18/10 - 12:24 pm
Athenahealth
Abbott Laboratories
Beckman Coulter
Agilent
AstraZeneca
Provenge
Dendreon
Benlysta
Human Genome Sciences
Telaprevir
Vertex Pharmaceuticals
Biotech Calendar: FDA Drug Approvals in 2011
TheStreet.com
Mon, 12/13/10 - 12:26 pm
MannKind
Afrezza
Alimera
pSivida
Seattle Genetics
brentuximab vedotin
Illuvien
AstraZeneca
Zictifa
Clinical Data
Vilazodone
Orexigen
Contrave
Bristol-Myers Squibb
Yervoy
Pfizer
Protalix BioTherapeutics
UPLYSO
Xiafaxan
Salix
Human Genome Sciences
Benlysta
Dendreon
Provenge
InterMune
Esbriet
Cell Therapeutics
pixantrone
Forest Labs
Daxas
MELA Sciences
MelaFind
XenoPort
GSK
Horizant
Spectrum Pharmaceuticals
Fusilev
Adventrx
Vertex Pharmaceuticals
Telaprevir
Vertex Files for Hep C Drug Approval
TheStreet.com
Tue, 11/23/10 - 10:36 am
hepatitis C
Vertex Pharmaceuticals
FDA
Telaprevir
Vertex Pharma reports positive results for experimental hepatitis C drug in African Americans
Yahoo/AP
Mon, 11/1/10 - 01:50 pm
hepatitis C
Vertex Pharmaceuticals
Telaprevir
Bristol-Myers Squibb
Merck
JNJ
Vertex, Merck Drugs Help More with Faster Cure for Hepatitis C in Studies
Bloomberg
Sat, 10/30/10 - 12:41 pm
Vertex Pharmaceuticals
Merck
hepatitis C
Telaprevir
Roche
Pegasys
Vertex Quarter Blemished by Hep C Hiccup
TheStreet.com
Tue, 10/26/10 - 07:19 am
Vertex Pharmaceuticals
earnings
hepatitis C
Telaprevir
Vertex Edges Merck In First Round of Hepatitis C Fight
Forbes
Mon, 10/4/10 - 05:21 pm
Merck
Vertex Pharmaceuticals
hepatitis C
Telaprevir
protease inhibitors
Idenix Hopes to Resume Course With Hepatitis C Drugs by Year's End
Seeking Alpha
Sun, 09/12/10 - 11:17 am
Idenix
hepatitis C
Bristol-Myers Squibb
ZymoGenetics
Vertex Pharmaceuticals
Telaprevir
Regulus
GSK
Merck
Vertex Cures Hard-to-Treat Hep C Patients
TheStreet.com
Tue, 09/7/10 - 05:01 pm
Vertex Pharmaceuticals
hepatitis C
Telaprevir
Dang! This Drug Is Shining Brighter
Motley Fool
Wed, 08/11/10 - 05:40 pm
Vertex Pharmaceuticals
hepatitis C
Merck
Telaprevir
Boceprevir
Roche
PegIntron
Pegasys
Vertex: At the Finish Line for a Hepatitis C Cure
Seeking Alpha
Tue, 08/10/10 - 07:33 am
Vertex Pharmaceuticals
hepatitis C
Merck
Telaprevir
Boceprevir
No Nail Yet, but Vertex Creeps Up to Merck's Coffin
Motley Fool
Thu, 08/5/10 - 09:27 am
Merck
Vertex Pharmaceuticals
Telaprevir
Boceprevir
hepatitis C
How Eli Lilly Let a Billion-Dollar Molecule Slip Away, and Make a Fortune for Vertex
Xconomy
Wed, 08/4/10 - 07:52 am
Vertex Pharmaceuticals
Eli Lilly
Telaprevir
hepatitis C
Vertex: A New Era In HCV Drug Development
Seeking Alpha
Tue, 07/20/10 - 07:18 am
HCV
Vertex Pharmaceuticals
Schering Plough
Telaprevir
Vertex Leaps Ahead: Hepatitis C Drug Produces Encouraging Results
Seeking Alpha
Tue, 06/1/10 - 05:46 am
Vertex Pharmaceuticals
hepatitis C
Merck
Telaprevir
Boceprevir
Vertex Hepatitis C Drug Cures 75% of Patients
TheStreet.com
Tue, 05/25/10 - 05:24 pm
Vertex Pharmaceuticals
hepatitis C
Telaprevir
Vertex Awaits Final Proof that Hepatitis C Drug Works
Motley Fool
Tue, 05/18/10 - 09:43 am
Vertex Pharmaceuticals
hepatitis C
Telaprevir
Vertex Hep C Drug Cures 80% at New Dose: Study
The Street
Sun, 11/1/09 - 09:08 am
Vertex Pharmaceuticals
Telaprevir
hepatitis C
Vertex Hep C Drug Improves Cure Rates
TheStreet.com
Wed, 10/28/09 - 07:39 am
hepatitis C
Vertex Pharmaceuticals
Telaprevir

Pages